Search results
Results from the WOW.Com Content Network
A Comparison of International Guidelines on Goal Blood Pressure and Initial Therapy for Adults With Hypertension (adapted from JNC 8 guidelines [1]) Guideline Population Goal blood pressure (mmHg) Initial treatment options ESC 2024 [2] General 120–129/70–79
The European Society of Cardiology (ESC), [25] and National Institute for Health and Care Excellence (NICE) [27] guidelines recommend that if the patient has a CHA 2 DS 2-VASc score of 2 and above, oral anticoagulation therapy (OAC) with a vitamin K antagonist (VKA, e.g. warfarin with target INR of 2-3) or one of the direct oral anticoagulant ...
The ESC produces clinical practice guidelines for cardiology professionals from evidence-based clinical trials data. The guidelines aim to present all the relevant evidence on a particular clinical issue in order to help physicians weigh the benefits and risks of particular diagnostic or therapeutic procedures.
The guidelines issued by the European Society of Cardiology (ESC) in 2016, mention cardiac contractility modulation therapy as a therapy option to be considered in selected group of patients with HF. Mostly these guidelines are endorsed by national cardiac societies in individual countries within the European Union. [20] [22]
ESC/HFA Guideline on Diagnosis & treatment of acute and chronic heart failure (McMurray et al., EHJ 2012) [27] HFA/WGTE of ESC Consensus on thromboembolism & anti-thrombotic therapy in heart failure with sinus rhythm (Lip et al. Eur J HF 2012) [28] ESH/ESC Guidelines for the management of arterial hypertension. Reviewer. (Mancia et al. EHJ 2013 ...
HAS-BLED is a scoring system developed to assess 1-year risk of major bleeding in people taking anticoagulants for atrial fibrillation (AF). It was developed in 2010 with data from 3,978 people in the Euro Heart Survey. [1]
PHOENIX — At least one person is dead and multiple people are injured Monday after private jets collided at an Arizona airport, authorities said, the latest incident at a time of heightened ...
The SAMe-TT 2 R 2 score [1] [2] is a clinical prediction rule to predict the quality of vitamin K antagonist anticoagulation therapy as measured by time in therapeutic INR range (TTR) (VKA e.g. warfarin). [3]